Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients

NCT01554059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

DRUG: Bevacizumab
DRUG: Oxaliplatin
DRUG: 5-FU
RADIATION: Radiotherapy

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University